“In this study we pioneered a totally new treatment for stroke, and possibly for all neurological disease”
In the latest in a series of experiments testing the use of stem cells to treat neurological disease, researchers at Henry Ford Hospital have shown for the first time that microscopic material in the cells offers a “robust” treatment for crippling stroke.
“In this study we pioneered a totally new treatment for stroke, and possibly for all neurological disease,” says Michael Chopp, Ph.D., scientific director of the Henry Ford Neuroscience Institute.
It focused on exosomes, blister-like microscopic “bubbles” that once were thought to carry and get rid of “old” proteins that were no longer needed by the body. After they were recently found to also carry RNA, whole new fields of study were suggested – including the pioneering work at Henry Ford.
The research team found that after inducing stroke in lab rats, injecting exosomes containing this genetic material into their blood prompted remodeling of the affected brain, including increased production of new brain cells, blood vessels and neural rewiring. Together, these effects significantly improved neurological function that had been impaired by stroke.
Using bone marrow from the adult rats, the researchers extracted stem cells – specifically mesenchymal cells, or MSCs – that were then employed to generate exosomes.
The researchers induced stroke by occluding an artery in the brain of each rat to block blood flow for two hours. Twenty-four hours later, they injected the exosomes into a vein in each rat’s tail.
The rats’ physical agility and neurological responses were tested before stroke and after treatment with the exosomes, and the results were compared.
“All rats showed severe functional loss one day after treatment, but gradual and eventually significant improvement during the four-week period that followed,” Dr. Chopp says. “This discovery provides a novel treatment for stroke, and possibly other neurological diseases.”
The Latest on: Treatment for Stroke
- Low systolic BP goal after stroke decreases risk for orthostatic hypotensionon September 9, 2019 at 6:45 am
Among patients with recent stroke, BP treatment to a target of less than 130 mm Hg systolic was linked to lower risk for orthostatic hypotension compared with treatment to a target of 130 mm Hg to 149 ...
- Aggressive blood pressure treatment not risky for seniors: studyon September 8, 2019 at 12:33 pm
It included more than 2,800 patients, average age 63, who had recently suffered a stroke. Half received more aggressive treatment to lower their blood pressure to below 130/80 mm Hg. The others got ...
- There is precedent for ailing Ginsburg to remain on Supreme Courton September 8, 2019 at 10:00 am
Unexpected death In the days before effective diagnosis and treatment of cardiovascular ... in ill health Frankfurter bowed out after a 1962 stroke and died three years later.
- No added dizzy episodes for adults on more intensive blood pressure-lowering treatmenton September 8, 2019 at 12:43 am
Adults who received more intensive treatment to lower their blood pressure ... The study of more than 2,800 adults, average age 63 with a recent stroke, found that a lower systolic blood pressure ...
- FOR YOUR HEALTH Peripheral artery disease — something else to worry about?on September 7, 2019 at 4:43 am
The good news is that early diagnosis and treatment can help you to manage — or even reverse ... To be clear, people who have PAD also have a higher risk for heart attack and stroke. With those points ...
- Column: Medicaid expansion right treatment for NC's rural hospitalson September 5, 2019 at 12:00 pm
Medicaid expansion could, in one stroke, profoundly improve the physical and economic health of rural communities. Expansion would ensure lifesaving care for hundreds of thousands of North Carolinians ...
- Rapid Outpatient Treatment Strategy Is Safe and Feasible for TIA and Minor Strokeon September 5, 2019 at 4:00 am
Researchers created the first outpatient integrated treatment strategy for the management of TIA and minor stroke, called the Rapid Access Vascular Evaluation–Neurology (RAVEN). A rapid outpatient ...
- NIH trial aims to improve drug discovery for ischemic strokeon September 4, 2019 at 8:50 am
The National Institutes of Health (NIH) has announced it will fund a nationwide preclinical trial platform called the Stroke Preclinical Assessment Network (SPAN) to ensure candidate new treatments ...
- Neurotechnology-aided Interventions for Upper Limb Motor Rehabilitation in Severe Chronic Strokeon September 2, 2019 at 9:17 pm
We encourage the identification of objective biomarkers for stroke recovery for patients' stratification and to tailor treatments. Furthermore, the advantage of longitudinal personalized trial designs ...
- Researchers hope stem cell trial will make headway for stroke recoveryon August 27, 2019 at 3:14 pm
Burgin says that right now, most stroke recovery treatments are limited to conventional therapy. He says there isn't medication that helps with recovery. "This would be kicking the door open to an ...
via Google News and Bing News